Search Blog
Categories
January 2014
M T W T F S S
« Dec   Feb »
 12345
6789101112
13141516171819
20212223242526
2728293031  

Tags

eResearch Posts Perspective on Microbix Biosystems Inc.

admin

By eResearch Corporation Microbix
Biosystems Inc. focuses on developing and commercializing biological products
and technologies through leveraging its Core Base Business of developing
infectious disease antigens (virology) for sale to large diagnostic kit
manufacturers.
 

The Company has reported Q4 and full-year F2013
results, with revenue for F2013 up 14% compared with F2012. Microbix
has provided updates on its thrombolytic drug Kinlytic™ (Urokinase)
as well as announcing patent litigation against Novartis Vaccines and
Diagnostics. 

Read more in the Perspective here:  Microbix Biosystems 

eResearch
is a primary source for professional investment research, focused on small- and
mid-cap companies. Our research and analysis is of institutional quality, and
has the potential for reaching millions of global investors through our
extensive electronic distribution network. 

eResearch
posts all its reports and articles on its website, eresearch.ca,
and subscription is FREE. 

Contact:

eResearch: Bob Weir, CFA,
Director of Research
Telephone:
(416) 703-6258
email:
bweir@eresearch.ca